Eric Schlorff (@schlorfferic) 's Twitter Profile
Eric Schlorff

@schlorfferic

CEO of SeaStar Medical

ID: 1258355890702348288

linkhttp://www.seastarmedical.com calendar_today07-05-2020 11:20:11

21 Tweet

199 Followers

58 Following

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

SeaStar Medical is proud to support the ADQI Conference on Extracorporeal Therapies, June 9-12 in Vicenza, Italy Learn more about ADQI's important initiatives at bit.ly/3CmcsTm #AKI #CriticalCare #ICU $ICU

SeaStar Medical is proud to support the ADQI Conference on Extracorporeal Therapies, June 9-12 in Vicenza, Italy

Learn more about ADQI's important initiatives at bit.ly/3CmcsTm

#AKI #CriticalCare #ICU $ICU
David Shapiro - CEO of B2i Digital, Inc. (@davidshapironyc) 's Twitter Profile Photo

Welcome SeaStar Medical (NASDAQ:$ICU) to the Maxim Group's Virtual Healthcare Conference hubs.li/Q01TL9ZQ0 SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs.

Welcome SeaStar Medical  (NASDAQ:$ICU) to the Maxim Group's Virtual Healthcare Conference hubs.li/Q01TL9ZQ0 SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs.
B2i Digital (@b2idigital) 's Twitter Profile Photo

Welcome SeaStar Medical (NASDAQ:$ICU) to the Maxim Group's Virtual Healthcare Conference hubs.li/Q01TLhkg0 SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs.

Welcome SeaStar Medical  (NASDAQ:$ICU) to the Maxim Group's Virtual Healthcare Conference hubs.li/Q01TLhkg0 SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs.
SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

Learn how our Selective Cytopheretic Device (SCD) modulates immune effector cells responsible for a dysregulated immune response. #MedTech #MedDevice #SCD #AKI #ICU $ICU

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

At SeaStar Medical, we are fighting the effects of a dysregulated immune response. Here’s a closer look at how our novel Selective Cytopheretic Device (SCD) deactivates inflammatory neutrophils & monocytes to restore immune balance. #MedDevice #ICU $ICU

Health Stocks News (@health_stocks) 's Twitter Profile Photo

SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients - Health Stocks Hub $ICU healthstockshub.com/news/nasdaq/ic…

Critical Care Time (@critcaretime) 's Twitter Profile Photo

Part 2 of our episode on Undifferentiated Shock just dropped! Learn: - 4 categories of shock (obstructive, cardiogenic, distributive, hypovolemic) - how physical exam & POCUS can help you identify the cause open.spotify.com/show/1I2czz7cK…

Critical Care Time (@critcaretime) 's Twitter Profile Photo

🚨Get Excited! New episode of Critical Care Time drops TOMORROW (& every other Monday)! 🎧Subscribe & never miss an episode: Apple podcasts.apple.com/us/podcast/cri… Google podcasts.google.com/feed/aHR0cHM6L… Spotify open.spotify.com/show/1I2czz7cK… 💌sign up for the CCT mailing list: criticalcaretime.com

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

In honor of the First International Conference of Critical Care Nephrology in Children taking place in London later this month, SeaStar Medical will be sharing some key facts on pediatric acute kidney injury in the run-up to this important meeting #PedAKI #CCNC #MedTwitter

In honor of the First International Conference of Critical Care Nephrology in Children taking place in London later this month, SeaStar Medical will be sharing some key facts on pediatric acute kidney injury in the run-up to this important meeting #PedAKI #CCNC #MedTwitter
SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

Mortality rates in children with AKI and multi-organ dysfunction requiring continuous kidney replacement therapy (CKRT) continues to approach 50%. (Goldstein, et al. KI Reports. 2021). SeaStar Medical is fighting to change these outcomes- more at seastarmedical.com $ICU #AKI

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

SeaStar Medical is proud to be a Platinum Sponsor of the First International Conference of Critical Care Nephrology in Children, taking place July 27-29 in London, UK #CriticalCare #MedTwitter $ICU #CCNC

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

This week, our Chief Medical Officer and retired Army physician, Dr. Kevin Chung, MD, spoke at the session "Cellular Therapeutics for Treatment of Shock and Trauma at the Military Health System Research Symposium" (MHSRS) about the life-saving potential of our SCD device #MHSRS

This week, our Chief Medical Officer and retired Army physician, Dr. Kevin Chung, MD, spoke at the session "Cellular Therapeutics for Treatment of Shock and Trauma at the Military Health System Research Symposium" (MHSRS) about the life-saving potential of our SCD device #MHSRS
SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

"SeaStar Medical Gets Third Breakthrough Nod for Selective Cytopheretic Device" - view the full article on BioWorld HERE: bioworld.com/articles/70216… #mednews #bioworld #medtech #ICU $ICU

SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

SeaStar Medical will be holding investment community meetings Jan. 8-11 at J.P. Morgan Healthcare week in San Francisco. Join CEO, Eric Schlorff Eric Schlorff and CMO Kevin Chung, MD. Kevin K. Chung, MD For more information, contact Jody Cain at LHA Investor Relations: [email protected]

SeaStar Medical will be holding investment community meetings Jan. 8-11 at J.P. Morgan Healthcare week in San Francisco. Join CEO, Eric Schlorff <a href="/SchlorffEric/">Eric Schlorff</a> and CMO Kevin Chung, MD. <a href="/chungk1031/">Kevin K. Chung, MD</a>

For more information, contact Jody Cain at LHA Investor Relations: JCain@lhai.com
SeaStarMedical (@seastarmedical) 's Twitter Profile Photo

In this newly published paper, led by Dr. Jeffrey Dellavolpe and team, read about the role our SCD played in a groundbreaking sequential extracorporeal treatment strategy of a 28-year-old patient who developed streptococcal toxic shock syndrome with multi-organ failure.